# Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C

> **NCT00446940** · PHASE2 · COMPLETED · sponsor: **Bader, Ted, M.D.** · enrollment: 16 (estimated)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** rosuvastatin
- **DRUG:** atorvastatin

## Key facts

- **NCT ID:** NCT00446940
- **Lead sponsor:** Bader, Ted, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** —
- **Final completion:** 2007-03
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2008-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00446940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00446940, "Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00446940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*